Skip to main content

Project #74:
Investigating the effect of SGLT2is on COVID-19 outcomes

This study is investigating the use of sodium glucose cotransporter 2 inhibitors (SGLT2is) on the risk of COVID-19 outcomes in the general population.

  • Study lead: John Tazare
  • Organisation: University of Oxford and London School of Hygiene and Tropical Medicine
  • Project type: Research
  • Topic area: Risk from COVID (short term) [e.g. hospitalisation/death]